TLRY Tilray, Inc. - Class 2
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was incorporated in 2018 and is headquartered in Nanaimo, Canada.
$21.38 -1.27 (-5.61%)
As of 03/05/2021 13:44:55 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Drug Manufacturers—Specialty &
Canada
USA
07/19/2018
171,757,688
59,209,500
$3,890,311,633
0.00%
SEC Edgar Online
10-Q
10-K
88688T100
US88688T1007
BDD1B29
Common stocks
Mid cap
Health Care
Drug Manufacturers—Specialty &
Canada
USA
07/19/2018
171,757,688
59,209,500
$3,890,311,633
0.00%
SEC Edgar Online
10-Q
10-K
88688T100
US88688T1007
BDD1B29
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-14.35
9.60
18.48
-72.50%
-128.79%
9.60
18.48
-72.50%
-128.79%